Feds say Porsche-driving medical marijuana sellers are flouting the rulesLOS ANGELES - Federal agents trailed Sparky Rose as he drove a Porsche Carrera convertible to his medical marijuana clinic.
Under California law, clinics are supposed to dispense marijuana just to seriously ill people and clinic owners are to get only “reasonable compensation.” But to the U.S. Drug Enforcement Administration, the sports car suggested that Rose might be pocketing big money from his purportedly nonprofit clinic, New Remedies Cooperative.
Rose was arrested in October and accused of illegal drug trafficking — charges he denies. According to court papers, an investigation turned up records showing $2.3 million was deposited in a New Remedies bank account over eight months starting in December 2005, and Rose wrote himself weekly checks of $9,600.
<snip>
West Hollywood City Councilman Jeff Prang said the federal government should leave it to local governments to monitor and regulate marijuana dispensaries that provide relief for those suffering from cancer, Parkinson’s, AIDS and other debilitating diseases.
“It’s a real sad day for the DEA if these type of facilities are that high on the list of priorities,” he said.
More:
http://www.msnbc.msn.com/id/17558116/_____________________________________________________________________________________________________
Anyone heard when the DEA will begin pursuing Bentley- and Maybach-drivin' CEOs of big pharma companies?By my calculations, the guy referenced in the MSNBC article pays himself about $500,000 per year. By comparison, here are salaries of the CEOs some leading pharmaceutical companies.
*BMS: $31,424,000 including salary, bonus and other compensation in 1999.
**Pfizer: $16,419,270 in total compensation including stock option grants from Pfizer Inc. in 2005.
*Merck: $6,132,702 in total compensation including stock option grants* from Merck & Co. Inc. in 2005.
*Warn-Lam: $22,061,000 including salary, bonus and other compensation in 1999
**Schering-Plough: $18,553,024 in total compensation including stock option grants* from Schering-Plough Corporation in 2005.
**Abbott Laboratories: $14,499,982 in total compensation including stock option grants* from Abbott Laboratories in 2005.
**Eli Lilly and Company: $11,943,955 in total compensation including stock option grants from Eli Lilly and Company in 2005.
*AHP: $4,093,000, including salary, bonus and other compensation in 1999.
**AMGEN: $11,193,465 in total compensation including stock option grants from Amgen Inc. in 2005.
Pharm & Upjohn, $2,366,000 including salary, bonus and other compensation in 1999.
SOURCES:
*ACT UP/New York:
http://www.actupny.org/reports/durban-licensing.html**AFL/CIO:
http://www.aflcio.org/corporatewatch/paywatch/ceou/database.cfm